Suzette Oelofse

8.4k total citations
19 papers, 230 citations indexed

About

Suzette Oelofse is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Suzette Oelofse has authored 19 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Suzette Oelofse's work include Tuberculosis Research and Epidemiology (13 papers), Diagnosis and treatment of tuberculosis (5 papers) and Pneumonia and Respiratory Infections (4 papers). Suzette Oelofse is often cited by papers focused on Tuberculosis Research and Epidemiology (13 papers), Diagnosis and treatment of tuberculosis (5 papers) and Pneumonia and Respiratory Infections (4 papers). Suzette Oelofse collaborates with scholars based in South Africa, United Kingdom and Canada. Suzette Oelofse's co-authors include Keertan Dheda, Aliasgar Esmail, Mohammed Fadul, Robin M. Warren, Elize Pietersen, Phindile Gina, Jason Limberis, Nora Engel, Nitika Pant Pai and Anja Krumeich and has published in prestigious journals such as Nature Medicine, Journal of Clinical Microbiology and European Respiratory Journal.

In The Last Decade

Suzette Oelofse

15 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzette Oelofse South Africa 7 173 112 45 32 29 19 230
C Ponnuraja India 9 147 0.8× 118 1.1× 48 1.1× 6 0.2× 9 0.3× 26 248
Cassidy Henegar United States 10 162 0.9× 63 0.6× 18 0.4× 25 0.8× 20 0.7× 28 269
Divya Sebastian United States 7 64 0.4× 71 0.6× 100 2.2× 45 1.4× 110 3.8× 14 324
Carlotta Cerva Italy 10 145 0.8× 107 1.0× 32 0.7× 5 0.2× 10 0.3× 24 249
Henan Xin China 12 208 1.2× 202 1.8× 143 3.2× 10 0.3× 34 1.2× 36 354
Grace Muzanyi Uganda 6 238 1.4× 181 1.6× 94 2.1× 7 0.2× 29 1.0× 14 337
Simon Tiberi United Kingdom 6 305 1.8× 99 0.9× 56 1.2× 7 0.2× 29 1.0× 10 402
Colina Yim Canada 12 69 0.4× 585 5.2× 15 0.3× 31 1.0× 13 0.4× 22 692
Kenv Pan China 3 251 1.5× 53 0.5× 23 0.5× 6 0.2× 12 0.4× 7 306
Brenda Mungai Kenya 4 204 1.2× 126 1.1× 55 1.2× 11 0.3× 21 0.7× 6 298

Countries citing papers authored by Suzette Oelofse

Since Specialization
Citations

This map shows the geographic impact of Suzette Oelofse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzette Oelofse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzette Oelofse more than expected).

Fields of papers citing papers by Suzette Oelofse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzette Oelofse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzette Oelofse. The network helps show where Suzette Oelofse may publish in the future.

Co-authorship network of co-authors of Suzette Oelofse

This figure shows the co-authorship network connecting the top 25 collaborators of Suzette Oelofse. A scholar is included among the top collaborators of Suzette Oelofse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzette Oelofse. Suzette Oelofse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Scott, Alex, Tahlia Perumal, Anil Pooran, et al.. (2025). Clinical evaluation of computer-aided digital x-ray detection of pulmonary tuberculosis during community-based screening or active case-finding: a case–control study. The Lancet Global Health. 13(3). e517–e527. 3 indexed citations
2.
Kwak, Nakwon, Catherine Berry, Angela M. Crook, et al.. (2025). Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: an individual patient data meta-analysis. European Respiratory Journal. 66(2). 2500315–2500315.
3.
Esmail, Aliasgar, Suzette Oelofse, Brandon Reyneke, et al.. (2025). VIDAS® TB-IGRA assay for diagnosing tuberculosis infection in people living with HIV: A preliminary study. International Journal of Infectious Diseases. 158. 107955–107955.
4.
Scott, Alex, Mohammed Limbada, Tahlia Perumal, et al.. (2024). Integrating molecular and radiological screening tools during community-based active case-finding for tuberculosis and COVID-19 in southern Africa. International Journal of Infectious Diseases. 145. 107081–107081. 2 indexed citations
5.
Esmail, Aliasgar, Alex Scott, Lindsay Wilson, et al.. (2024). Diagnostic Performance of Unstimulated IFN-γ (IRISA-TB) for Pleural Tuberculosis: A Prospective Study in South Africa and India. Open Forum Infectious Diseases. 11(10). ofae533–ofae533.
6.
Scott, Alex, Tahlia Perumal, Ameer Hohlfeld, et al.. (2024). Diagnostic Accuracy of Computer-Aided Detection During Active Case Finding for Pulmonary Tuberculosis in Africa: A Systematic Review and Meta-analysis. Open Forum Infectious Diseases. 11(2). ofae020–ofae020. 6 indexed citations
7.
Wilson, Lindsay, Stuart Meier, Tariq Ganief, et al.. (2023). Proteomic Profiling of Urine From Hospitalized Patients With Severe Pneumonia due to SARS-CoV-2 vs Other Causes: A Preliminary Report. Open Forum Infectious Diseases. 10(10). ofad451–ofad451. 2 indexed citations
8.
Dheda, Keertan, Chad M. Centner, Lindsay A. Wilson, et al.. (2023). Intensive Care Unit Sluice Room Sinks as Reservoirs and Sources of Potential Transmission of Carbapenem-Resistant Bacteria in a South African Tertiary Care Hospital. Infection and Drug Resistance. Volume 16. 5427–5432. 2 indexed citations
9.
Esmail, Aliasgar, Philippa Randall, Suzette Oelofse, et al.. (2023). Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial. Nature Medicine. 29(4). 1009–1016. 17 indexed citations
11.
Oelofse, Suzette, Aliasgar Esmail, Andreas H. Diacon, et al.. (2021). Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts. The International Journal of Tuberculosis and Lung Disease. 25(6). 453–460. 16 indexed citations
12.
Pai, Nitika Pant, Aliasgar Esmail, Paramita Saha‐Chaudhuri, et al.. (2021). Impact of a personalised, digital, HIV self-testing app-based program on linkages and new infections in the township populations of South Africa. BMJ Global Health. 6(9). e006032–e006032. 23 indexed citations
15.
Esmail, Aliasgar, Anil Pooran, Natasha F. Sabur, et al.. (2020). An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag. Journal of Clinical Microbiology. 58(10). 7 indexed citations
16.
Engel, Nora, Aliasgar Esmail, Suzette Oelofse, et al.. (2019). Alone But Supported: A Qualitative Study of an HIV Self-testing App in an Observational Cohort Study in South Africa. AIDS and Behavior. 24(2). 467–474. 30 indexed citations
17.
Limberis, Jason, Aliasgar Esmail, Suzette Oelofse, et al.. (2018). Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa. European Respiratory Journal. 51(5). 1800544–1800544. 82 indexed citations
18.
Tomasicchio, Michele, Aliasgar Esmail, Richard Meldau, et al.. (2018). An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells. Cancer Immunology Immunotherapy. 68(1). 71–83. 32 indexed citations
19.
Pai, Nitika Pant, Suzette Oelofse, Jana Daher, et al.. (2018). 1275. Will an App-Optimized HIV Self-testing Strategy Work for South Africans? Results From a Large Cohort Study. Open Forum Infectious Diseases. 5(suppl_1). S388–S388. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026